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Abstract
Background: Protein expression studies based on the two major intra-abdominal human fat depots, the subcutaneous and
the omental fat, can shed light into the mechanisms involved in obesity and its co-morbidities. Here we address, for the first
time, the identification and validation of reference proteins for data standardization, which are essential for accurate
comparison of protein levels in expression studies based on fat from obese and non-obese individuals.
Methodology and Findings: To uncover adipose tissue proteins equally expressed either in omental and subcutaneous fat
depots (study 1) or in omental fat from non-obese and obese individuals (study 2), we have reanalyzed our previously
published data based on two-dimensional fluorescence difference gel electrophoresis. Twenty-four proteins (12 in study 1
and 12 in study 2) with similar expression levels in all conditions tested were selected and identified by mass spectrometry.
Immunoblotting analysis was used to confirm in adipose tissue the expression pattern of the potential reference proteins
and three proteins were validated: PARK7, ENOA and FAA. Western Blot analysis was also used to test customary loading
control proteins. ENOA, PARK7 and the customary loading control protein Beta-actin showed steady expression profiles in
fat from non-obese and obese individuals, whilst FAA maintained steady expression levels across paired omental and
subcutaneous fat samples.
Conclusions: ENOA, PARK7 and Beta-actin are proper reference standards in obesity studies based on omental fat, whilst
FAA is the best loading control for the comparative analysis of omental and subcutaneous adipose tissues either in obese
and non-obese subjects. Neither customary loading control proteins GAPDH and TBB5 nor CALX are adequate standards in
differential expression studies on adipose tissue. The use of the proposed reference proteins will facilitate the adequate
analysis of proteins differentially expressed in the context of obesity, an aim difficult to achieve before this study.
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Introduction
Quantitative proteomic and genomic technologies have recently
revolutionized the search for disease-specific biomarkers or
molecular signatures, enabling a better understanding of molecular
events associated with disease development and progression, and
eventually proposing therapeutic targets. At the protein expression
level, confirmation of differences detected by proteomics is usually
carried out by complementary approaches like immunoblotting
analysis. Although classical Western Blot is typically used for
qualitative purposes, quantification and accurate comparison of
protein levels is feasible by the inclusion of reference standard
proteins to better assess biological and experimental variations.
Ideally, a ‘‘good’’ internal reference control is expected to show
constant expression levels across samples within a given experi-
mental design. There is mounting evidence that housekeeping
proteins used as ubiquitous loading controls, such as glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH), Beta-actin and
tubulin beta chain (TBB5) often show varying expression levels
across samples and experimental conditions [1,2,3]. Since these
proteins are also used in human adipose tissue expression studies,
there are unmet needs to validate and/or identify a set of stable
reference proteins for data standardization in this tissue.
Adipose tissue, previously seen as an inert fat depot, is now
recognized as a highly active organ with many important
physiological and pathological roles. This endocrine organ cross-
talks with other essential organs acting as a crucial regulator of
whole-body homeostasis [4,5]. Human adipose tissue comprises
two major intra-abdominal depots, the subcutaneous and the
omental fat depot. A number of epidemiologic studies have shown
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that the size of the omental, more than the subcutaneous, fat is
closely associated with a higher risk of obesity-related co-
morbidities, such as insulin resistance, type 2 diabetes and
cardiovascular disease [5,6]. However, the underlying mechanisms
for this association are not yet clear. Neither are the molecular
mechanisms that lead to and take part in the development of
obesity and the pathologies associated to obesity well understood.
Expression studies in adipose tissue are pivotal to gain insight
into the mechanisms involved in obesity and its co-morbidities,
and ultimately find novel markers and therapeutic targets.
Recently a number of genomic and proteomic studies have
revealed potential genes and proteins involved in obesity and/or
type 2 diabetes [7,8,9], as well as differentially expressed genes and
proteins in the omental and subcutaneous fat comparisons
[10,11,12,13,14,15]. Most studies resort to real time-PCR and
Western Blot to validate these genes and proteins, respectively;
however, despite that several genes have been proposed as suitable
endogenous controls in gene expression studies on adipose tissue
[16,17,18] no studies have attempted the identification and
validation of adequate protein reference standards. As a
consequence, expression studies continue to rely on customary
loading controls (GAPDH, Beta-actin, TBB5) with unproven
performance, which could overshadow the study conclusions
owing to misinterpretation of results.
In the quest for reliable protein markers (i.e. showing steady
expression) in human adipose tissue we have reanalyzed previously
data from two-dimensional fluorescence difference gel electropho-
resis (2D-DIGE) [10] and [19] for later protein identification by
matrix-assisted laser desorption/ionization mass spectrometry
(MALDI-MS) and Western Blot. Moreover we have studied, for
the first time to our knowledge, reference standards frequently
used in protein expression studies related to obesity research to
find out their suitability as loading controls in immunoblotting
analysis in human adipose tissue.
Methods
Ethics Statement
This study has been conducted according to the recommenda-
tions of the Declaration of Helsinki and was approved by the
Ethics Committees of Hospital Dr. Josep Trueta (Girona, Spain).
Signed informed consent was obtained from all subjects.
Biological samples
Omental and subcutaneous adipose tissue samples used in 2D-
DIGE analysis had been previously described [10] and [19].
Additional samples of omental and subcutaneous adipose tissue
were obtained from 20 men and 30 women, who had been
submitted for elective surgical procedures (cholecystectomy,
surgery of abdominal hernia and gastric by-pass surgery). Clinical
and biochemical characteristics of these 50 subjects are described
in Table S1. Non-obese subjects had a body mass index
(BMI),30 kg/m2 and obese subjects had a BMI.30 kg/m2.
During surgery, biopsies of adipose tissues were obtained after an
overnight fast, washed in chilled 9 g/L NaCl solution, partitioned
into pieces, and immediately frozen in liquid nitrogen and stored
at 280uC until protein extraction. The surgeon aimed to obtain
the samples from similar anatomical locations in all the subjects.
All subjects were of Caucasian origin and reported that their body
weight had been stable for at least three months before the study.
None of the subjects had type 2 diabetes or any other systemic
disease apart from obesity and all were free of any infections within
the previous month before the study. Liver disease and thyroid
dysfunction were specifically excluded by biochemical work-up.
Other exclusion criteria for those patients included the following:
1) clinically significant hepatic, neurological, or other major
systemic disease, including malignancy; 2) history of drug or
alcohol abuse, defined as .80 g/day, or serum transaminase
activity more than twice the upper normal range limit; 3) elevated
serum creatinine concentrations; 4) acute major cardiovascular
event in the previous 6 months; 5) acute illnesses and current
evidence of chronic inflammatory or infectious diseases; and 6)
mental illness rendering the subjects unable to understand the
nature, scope, and possible consequences of the analysis.
2D-DIGE separation and analysis
Protein extract preparation and separation by 2D-DIGE have
been independently described for study 1, which compared
omental and subcutaneous fat depots from obese individuals
[10] and for study 2, which compared omental adipose tissue from
non-obese and obese individuals [19]. Briefly, proteins were
extracted from adipose tissue biopsies and the concentration was
determined using the RC/DC Protein Assay (Bio-Rad Laborato-
ries, Hercules, CA, USA). Protein extracts were labelled with Cy2,
Cy3 or Cy5 fluorescent cyanine dyes, and were mixed and
separated on 2-DE gels using 24 cm pH 3–11 NL strips in the first
dimension and 12% SDS-PAGE gels in the second dimension.
After SDS-PAGE, gels were scanned with a Typhoon 9400
fluorescent scanner (GE Healthcare) at 100 mm resolution using
appropriate individual excitation and emission wavelengths and
filters. Gel images previously analyzed with the DeCyder software
(GE Healthcare) to detect the corresponding proteins differentially
expressed in either study 1 [10] and study 2 [19] were now
reanalyzed with DeCyder software v7 to reveal protein spots
which remained significantly unaffected (i.e. with average ratio
around 1) across samples in each study.
In-gel trypsin digestion and mass spectrometry
Protein spots which remained significantly unaffected across
samples as revealed by DeCyder software were selected for gel
excision from silver-stained gels, digested automatically and
analyzed in an Ultraflex MALDI TOF/TOF mass spectrometer
(Bruker Daltonik, Bremen, Germany) [20] to obtain the
corresponding MALDI-MS and MALDI-MS/MS spectra. In a
first step, MALDI-MS spectra were acquired by averaging 300
individual spectra in the positive ion reflector mode at 50 Hz laser
frequency in a mass range from 800 to 4000 Da. In a second step,
precursor ions showing in the MALDI-MS mass spectrum were
subjected to fragment ion analysis in the tandem (MS/MS) mode
to average 1000 spectra. Peak labeling, internal calibration based
on two trypsin autolysis ions with m/z = 842.510 and m/
z = 2211.105, as well as removal of known trypsin and keratin
peptide masses were performed automatically using the flexAna-
lysis 2.2 software (Bruker Daltonik). No smoothing or any further
spectral processing was applied. MALDI-MS and MS/MS spectra
were manually inspected in detail and reacquired, recalibrated
and/or relabeled using the aforementioned programs and
homemade software when necessary.
Database searching
MALDI-MS and MS/MS data were combined through the
BioTools 3.0 program (Bruker Daltonik) to search a nonredundant
protein database (NCBInr 20091022; ,7.06106 entries; National
Centre for Biotechnology Information, Bethesda, US), using the
Mascot 2.2 software (Matrix Science, London, UK; http://www.
matrixscience.com) [21]. Other relevant search parameters were
set as follows: enzyme, trypsin; fixed modifications, carbamido-
methyl (C); allow up to 1 missed cleavage; peptide tolerance
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620 ppm; MS/MS tolerance 60.5 Da. Protein scores greater
than 81 were considered significant (p,0.05).
Immunoblotting analysis
Fat tissue was homogenized in radioimmnuno precipitation
assay (RIPA) buffer as described in [10]. Protein extracts (10 mg)
were loaded, resolved on 10–14% SDS-PAGE and transferred to
Hybond ECL nitrocellulose membranes by conventional proce-
dures. Membranes were stained with 0.15% Ponceau red (Sigma-
Aldrich, St Louis, MO, USA) to ensure equal loading after transfer
and then blocked with 5% (w/v) BSA or dried nonfat milk in TBS
buffer with 0.1% Tween 20. The antibodies used for Western Blot
analysis revealed in each case single bands at the expected
molecular masses. The primary antibodies used were 1:10000
rabbit anti-ENOA (sc-15343), 1:200 goat anti-PARK7 (sc-27004),
1:1000 goat anti-FAA (sc-66223), 1:2000 goat anti-Beta-actin (sc-
1616), 1:500 goat anti-PGK1 (sc-17943), 1:5000 mouse anti-TBB5
(sc-134234), and 1:5000 rabbit anti-CALX (sc-11397) all from
Santa Cruz Biotechnology, Inc (Heidelberg, Germany) and 1:4000
mouse anti-GAPDH, AM4300 (Ambion, Austin, USA). Blots were
incubated with the appropriate IgG-HRP-conjugated secondary
antibody. Immunoreactive bands were visualized with ECL-plus
reagent kit (GE Healthcare). Blots were exposed for different
times; exposures in the linear range of signal were selected for
densitometric evaluation. Optical densities of the immunoreactive
bands were measured using Image J analysis software.
Immunohistochemistry
Five-micron sections of formalin-fixed paraffin-embedded
adipose tissue were deparaffinized and rehydrated prior to antigen
unmasking by boiling in 1 mM EDTA, pH 8. Sections were
blocked in normal serum and incubated overnight with the
following antibodies: rabbit anti-ENOA (sc-15343) at 1:100
dilution, goat anti-PARK7 (sc-27004) at 1:50 dilution, and goat
anti-FAA (sc-66223) at 1:50 dilution. Secondary antibody staining
was performed using the VECTASTAIN ABC kit (Vector
laboratories, Inc Burlingame, CA) and detected with diaminoben-
zidine (DAB, Vector Laboratories, Inc). Sections were counter-
stained with hematoxylin prior to dehydration and coverslip
placement. As a negative control, the entire immunohistochemical
procedure was performed on adjacent sections in the absence of
primary antibody.
Statistical analyses
Descriptive results of continuous variables are expressed as
mean 6 standard deviation (SD). Before statistical analysis,
normal distribution and homogeneity of the variances were
evaluated using Levene’s test. One-way ANOVA, for multiple
comparisons, using post-hoc by Bonferroni’s test (when equal
variances could be assumed), was used to compare groups. The
statistical analyses were performed using the program SPSS 16.0
(SPSS Inc., Illinois, USA). Statistical comparisons of the Western
Blot densitometry data were carried out using the Student’s t test
for paired (omental vs. subcutaneous) and independent (obese vs.
non-obese) samples, and results were expressed as means 6 SD
using SPSS. The coefficient of variation (CV) was also calculated.
Statistical significance was set at p,0.05.
Results
Reference proteins for comparative expression studies
between omental and subcutaneous adipose tissue
We had previously found over-expression of GAPDH in the
omental compared to the subcutaneous human adipose tissue [10].
Given that this protein is a customary loading control in
expression studies, we evaluated other common reference proteins,
namely Beta-actin and TBB5, as well as calnexin (CALX) in
omental and subcutaneous adipose tissue by Western Blot. We
have tested samples from 50 patients, including males and females
across a wide BMI range and a wide age range, as described in
Table S1. Beta-actin and CALX levels were higher in the omental
than in the subcutaneous fat (p,0.05), as was the case for
GAPDH, while TBB5 showed a very heterogeneous expression
profile across samples (coefficient of variation, CV = 59%). Figure 1
shows a representative group of samples to illustrate the expression
pattern of these proteins. Results demonstrate that neither
customary Beta-actin, TBB5 and GAPDH nor CALX are
adequate reference standards for protein expression studies
addressing the comparison of omental and subcutaneous samples.
In view of the lack of suitable standard proteins, a reanalysis was
accomplished with data from our previously published proteomic
study based on 2D-DIGE and MALDI-MS analyses [10] to
uncover appropriate reference standards. Twelve spots with
similar expression levels across samples were selected and
identified by MALDI-MS (Table 1 and Figure 2A).
Based on 2D-DIGE results, a set of three least-variable proteins,
namely enolase 1 (ENOA), phosphoglycerate kinase 1 (PGK1) and
fumarylacetoacetase (FAA), were evaluated by Western Blot in fat
tissue samples from the subjects included in the study. Figure 2B
shows expression levels of these three proteins in a representative
group of samples. Results demonstrate that FAA maintained
Figure 1. Protein expression levels in human omental and
subcutaneous adipose tissue. Representative Western Blot analysis
of Beta-actin, GAPDH, CALX and TBB5 in omental (O) and subcutaneous
(S) fat samples. Paired relative intensity values from band densitometry
in omental and subcutaneous fat samples from the same individual are
represented.
doi:10.1371/journal.pone.0030326.g001
Reference Proteins for Expression Studies in Fat
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e30326
T
a
b
le
1
.
C
an
d
id
at
e
re
fe
re
n
ce
p
ro
te
in
s
id
e
n
ti
fi
e
d
b
y
M
A
LD
I-
M
S
st
u
d
y.
S
p
o
ta
A
cc
e
si
o
n
C
o
d
e
N
C
B
I
A
cc
e
ss
io
n
C
o
d
e
S
w
is
s-
P
ro
t
P
ro
te
in
D
e
sc
ri
p
ti
o
n
M
a
sc
o
t
S
co
re
M
a
sc
o
t
E
x
p
e
ct
M
a
sc
o
t
Io
n
s
sc
o
re
M
W
(k
D
a
)
p
I
M
a
tc
h
e
d
/U
n
m
a
tc
h
e
d
p
e
p
ti
d
e
s
C
o
v
e
ra
g
e
O
m
e
n
ta
l
vs
.
su
b
cu
ta
n
e
o
u
s
1
g
i|1
1
9
5
9
7
6
4
0
P
D
IA
3
_
H
U
M
A
N
P
ro
te
in
d
is
u
lf
id
e
is
o
m
e
ra
se
fa
m
ily
A
,
m
e
m
b
e
r
3
,
is
o
fo
rm
C
R
A
_
a
2
7
8
1
.3
0
E-
2
1
9
5
5
4
.4
6
.7
8
1
3
/3
3
1
2
g
i|1
8
3
7
9
3
4
9
V
A
T
1
_
H
U
M
A
N
V
e
si
cl
e
am
in
e
tr
an
sp
o
rt
p
ro
te
in
1
2
2
0
8
.0
0
E-
1
6
8
8
4
2
.1
5
.8
8
7
/1
2
7
3
g
i|1
9
2
2
2
8
7
EC
H
S1
_
H
U
M
A
N
En
o
yl
-C
o
A
h
id
ra
ta
se
,
m
it
o
ch
o
n
d
ri
al
2
3
4
3
.2
0
E-
1
7
1
0
3
3
1
.8
8
.3
4
8
/2
2
6
4
g
i|3
4
2
0
1
8
1
W
D
R
1
_
H
U
M
A
N
W
D
R
1
p
ro
te
in
1
0
6
0
.0
0
0
2
7
4
5
8
.6
6
.4
1
2
/0
4
5
g
i|1
6
9
6
4
6
4
4
1
G
D
I2
_
H
U
M
A
N
G
D
P
d
is
so
ci
at
io
n
in
h
ib
it
o
r
2
is
o
fo
rm
2
1
8
4
3
.2
0
E-
1
2
8
0
4
6
.0
5
.9
1
7
/1
2
5
6
g
i|3
9
6
4
4
7
2
8
EN
O
A
_
H
U
M
A
N
En
o
la
se
1
1
4
3
4
.6
0
E-
0
8
8
0
2
9
.2
5
.8
7
6
/1
1
9
7
g
i|3
6
4
1
3
9
8
ID
H
1
_
H
U
M
A
N
N
A
D
P
-d
e
p
e
n
d
e
n
t
is
o
ci
tr
at
e
d
e
h
yd
ro
g
e
n
as
e
2
1
4
3
.2
0
E-
1
5
7
5
4
6
.9
6
.3
4
1
0
/2
2
3
8
g
i|4
7
5
8
6
3
8
P
R
D
X
6
_
H
U
M
A
N
P
e
ro
xi
re
d
o
xi
n
6
1
9
1
6
.3
0
E-
1
3
2
5
.1
6
1
0
/1
3
9
9
g
i|1
1
9
5
8
7
5
0
7
T
H
IL
_
H
U
M
A
N
A
ce
ty
l-
C
o
A
ac
e
ty
lt
ra
n
sf
e
ra
se
,
m
it
o
ch
o
n
d
ri
al
9
6
0
.0
0
2
7
4
2
1
.6
9
.2
8
1
/0
6
1
0
g
i|4
5
0
3
0
5
7
C
R
Y
A
B
_
H
U
M
A
N
C
ry
st
al
lin
,
al
p
h
a
B
1
3
4
3
.2
0
E-
0
7
8
9
2
0
.1
6
.7
6
7
/1
2
2
1
1
g
i|4
5
0
5
7
6
3
P
G
K
1
_
H
U
M
A
N
P
h
o
sp
h
o
g
ly
ce
ra
te
ki
n
as
e
1
1
9
4
8
.9
0
E-
1
5
1
2
0
4
5
.0
8
.3
5
/0
1
8
1
2
g
i|4
5
5
7
5
8
7
FA
A
_
H
U
M
A
N
Fu
m
ar
yl
ac
e
to
ac
e
ta
se
9
8
0
.0
0
1
8
7
9
4
6
.7
6
.4
6
2
/0
3
O
b
e
se
vs
.
n
o
n
-o
b
e
se
1
3
g
i|2
0
3
2
8
2
3
6
7
EN
O
A
_
H
U
M
A
N
En
o
la
se
1
2
9
8
1
.6
0
E-
2
3
4
7
.3
6
.9
9
1
9
/3
4
5
1
4
g
i|5
4
5
3
5
9
7
C
A
Z
A
1
_
H
U
M
A
N
F-
ac
ti
n
ca
p
p
in
g
p
ro
te
in
al
p
h
a-
1
su
b
u
n
it
2
0
3
5
.0
0
E-
1
4
1
0
3
3
3
.1
5
.4
5
5
/1
2
9
1
5
g
i|4
5
0
4
9
8
1
LE
G
1
_
H
U
M
A
N
G
al
e
ct
in
-1
2
1
2
1
.4
0
E-
1
6
1
5
5
1
5
.0
5
.3
4
3
/0
2
9
1
6
g
i|6
5
9
8
3
2
3
G
D
IB
_
H
U
M
A
N
G
D
P
d
is
so
ci
at
io
n
in
h
ib
it
o
r
2
is
o
fo
rm
1
4
1
0
9
.9
0
E-
3
5
1
3
5
5
1
.1
6
.1
1
1
8
/4
4
5
1
7
g
i|4
5
5
7
5
8
7
FA
A
_
H
U
M
A
N
Fu
m
ar
yl
ac
e
to
ac
e
ta
se
1
7
7
2
.0
0
E-
1
1
8
5
4
6
.7
6
.4
6
6
/1
1
4
1
8
g
i|9
9
5
1
9
1
5
SA
H
H
_
H
U
M
A
N
A
d
e
n
o
sy
lh
o
m
o
cy
st
e
in
as
e
is
o
fo
rm
1
1
8
3
5
.0
0
E-
1
2
9
0
4
8
.2
5
.9
2
5
/1
1
4
1
9
g
i|4
5
0
3
4
8
1
EF
1
G
_
H
U
M
A
N
Eu
ka
ry
o
ti
c
tr
an
sl
at
io
n
e
lo
n
g
at
io
n
fa
ct
o
r
1
g
am
m
a
3
6
3
5
.0
0
E-
3
0
1
6
5
5
0
.4
6
.2
5
1
6
/2
3
7
2
0
g
i|2
5
7
7
7
6
1
5
P
SD
7
_
H
U
M
A
N
P
ro
te
as
o
m
e
2
6
S
n
o
n
-A
T
P
as
e
su
b
u
n
it
7
1
4
5
7
.1
0
E-
1
0
5
9
3
7
.1
6
.2
9
4
/1
2
1
2
1
g
i|3
1
5
4
3
3
8
0
P
A
R
K
7
_
H
U
M
A
N
P
ar
ki
n
so
n
d
is
e
as
e
p
ro
te
in
7
2
4
1
1
.8
0
E-
1
9
1
3
9
2
0
.0
6
.3
3
5
/2
2
6
2
2
g
i|5
8
0
3
1
8
7
T
A
LD
O
_
H
U
M
A
N
T
ra
n
sa
ld
o
la
se
1
1
0
4
8
.9
0
E-
0
6
4
8
3
7
.7
6
.3
6
3
/1
1
0
2
3
g
i|1
1
9
6
1
9
0
0
9
P
G
K
1
_
H
U
M
A
N
P
h
o
sp
h
o
g
ly
ce
ra
te
ki
n
as
e
1
,
is
o
fo
rm
C
R
A
_
b
2
9
1
7
.4
0
E-
2
3
1
9
4
2
8
.0
9
.2
3
5
/2
2
3
2
4
g
i|4
5
0
3
5
7
1
EN
O
A
_
H
U
M
A
N
En
o
la
se
1
1
8
2
6
,3
0
E-
1
2
4
7
.5
7
,0
1
1
0
/2
3
2
P
ro
te
in
sp
o
ts
w
it
h
si
m
ila
r
e
xp
re
ss
io
n
le
ve
ls
ac
ro
ss
sa
m
p
le
s
w
e
re
id
e
n
ti
fi
e
d
b
y
M
A
LD
I-
M
S
af
te
r
co
m
p
ar
at
iv
e
an
al
ys
e
s
o
f
o
m
e
n
ta
l
vs
.
su
b
cu
ta
n
e
o
u
s
ad
ip
o
se
ti
ss
u
e
(s
p
o
ts
fr
o
m
1
to
1
2
)
an
d
o
m
e
n
ta
l
fa
t
fr
o
m
o
b
e
se
vs
.
n
o
n
-o
b
e
se
su
b
je
ct
s
(s
p
o
ts
fr
o
m
1
3
to
2
4
).
a
Sp
o
t
n
u
m
b
e
ri
n
g
as
in
Fi
g
u
re
2
A
(1
–
1
2
)
an
d
Fi
g
u
re
4
A
(1
3
–
2
4
).
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
0
3
0
3
2
6
.t
0
0
1
Reference Proteins for Expression Studies in Fat
PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e30326
steady expression levels across paired omental and subcutaneous
fat samples, with a CV of 16%, ENOA was over-expressed in the
omental fat biopsies compared to subcutaneous fat, and PGK1
showed variable expression levels across the majority of paired
samples, presenting a CV of 59% (Figure 2B). Consequently, FAA
was the most suitable loading control for studying differential
expression between omental and subcutaneous adipose tissue.
Reference proteins for comparative expression studies in
omental adipose tissue from obese and non-obese
individuals
The expression patterns of GAPDH, Beta-actin, TBB5 and
CALX were evaluated by immunoblotting analysis, using omental
fat protein extracts from non-obese and obese patients. Expression
levels of GAPDH, TBB5 and CALX were higher in obese
patients. GAPDH and TBB5 showed considerable intra-group
variation, especially TBB5 with CV = 70% (Figure 3). According-
ly, these proteins do not constitute appropriate loading controls in
comparative protein expression studies comprising non-obese and
obese individuals. On the contrary, results unveiled that Beta-actin
was an appropriate reference standard, albeit the moderate intra-
group variation observed for this protein (CV = 21%).
To uncover alternative suitable reference proteins, a reanalysis
was accomplished with data from our previous proteomic study
comparing omental fat biopsies from six obese and six non-obese
subjects based on 2D-DIGE [19]. Twelve protein spots with steady
levels across samples were selected and excised from silver-stained
gels, digested with trypsin, and analyzed by MALDI-MS (Table 1
and Figure 4A), including ENOA, FAA and Parkinson disease
protein 7 (PARK7), which showed the least variability across
samples according to DeCyder software. This is illustrated in
Figure 4B, where representative zoomed images of 2D-DIGE gels
around PARK7 spot demonstrate sustained levels of this protein,
with a fold change ratio between the two sample groups of 1.07.
These three proteins were further evaluated by Western Blot
using omental samples from non-obese and obese subjects. This
study revealed nearly invariable ENOA and PARK7 levels in
obese and non-obese individuals, together with a highly homoge-
neous intra-group expression pattern across samples (SD 0.11 and
0.13 for non-obese and obese samples, respectively, with ENOA;
SD 0.2 and 0.14 with PARK7). CV values were 16% for ENOA
and 22% for PARK7, the latter being similar to the CV value of
Beta-actin. FAA exhibited slightly heterogeneous expression
patterns across samples, with a CV of 35% (Figure 4C). Therefore,
our studies unveiled that ENOA, PARK7 and Beta-actin can be
considered adequate reference proteins for expression studies in
human omental adipose tissue in non-obese and obese subjects.
To extend the validity of the proposed protein markers to tissues
from obese type 2 diabetic patients, the expression levels of
ENOA, PARK7, FAA, Beta-actin, GAPDH, TBB5 and CALX
levels were compared by immunoblotting analysis. We used
omental adipose tissue proteins from non-obese and non-diabetic
subjects vs. obese and type 2 diabetic patients. Type 2 diabetes was
diagnosed when fasting serum glucose was above 126 mg/dl or
serum glucose 2 hour after oral glucose tolerance test was above
200 mg/dl, repeated at least 2 times. ENOA and PARK7 showed
the most steady expression profiles across samples with CV of 13%
and 20%, respectively, therefore revealing as the most appropriate
reference standards when comparing non-diabetic and type 2
diabetic subjects (Figure S1).
Figure 2. Proteins identified by 2D-DIGE and MS showing sustained expression levels in omental and subcutaneous adipose
tissues. Protein extracts from subcutaneous and omental adipose tissue paired samples were analyzed by 2D-DIGE [10]. Proteins were revealed by
AgNO3 staining and based on DeCyder analysis the spots of interest were excised from the gel and subject to MS-based identification. A
representative silver-stained gel is shown; the numbers correspond to 12 selected protein spots as indicated in Table 1 (A). Representative Western
Blot analysis of selected proteins in omental (O) and subcutaneous (S) fat samples. Paired relative intensity values from band densitometry in fat
samples from the same individual are represented (B).
doi:10.1371/journal.pone.0030326.g002
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Discussion
Reference standards with steady expression across tissue sample
cohorts are indispensable in clinical research to reliably determine
altered proteins associated to human disease. We have successfully
identified and validated proteins with sustained expression levels to
be used as reference standards in expression studies on human
adipose tissue with relevance to the pathophysiology of obesity. An
objective of many differential expression studies is to define protein
profiles that can distinguish between normal and pathological
states, enabling a better understanding of molecular events
associated with disease development and progression, and
eventually proposing novel biomarkers or therapeutic targets.
Confirmation of differences at the protein expression level is
usually carried out by immunoblotting analysis, which becomes
quantitative by using loading controls. Nevertheless, these
quantitative measurements are prone to error due to overloading
of internal standards and over-reliance on normalization [1,3].
With the antibodies and experimental conditions used in this
study, 10 mg of proteins have enabled linearity in Western Blot
analysis. This emphasizes the need to optimize experimental
conditions for a given assay, including avoidance of blot
overexposure to ensure a linear relation between protein
concentration and Western Blot signal.
Most reference controls consist of housekeeping genes and
proteins, as these are constitutively expressed for functions
required for cell maintenance. However, lately many gene
expression studies, a few of them based on adipose tissue, have
shown that several of the commonly used housekeeping genes may
be unsuitable due to the influence of physiological and
pathological events on their expression [17,18]. Although a few
protein studies have addressed this point [2,22], no systematic
work has evaluated customary reference proteins in adipose tissue,
and therefore expression analyses continue to rely on Beta-actin,
TBB5, GAPDH and/or CALX [23,24,25,26,27,28,29]. It is
noteworthy that constitutive expression in cells does not preclude
regulation; in fact our results show that most proteins currently
used as loading controls cannot be regarded suitable reference
standards in human adipose tissue. While Beta-actin is the only
customary reliable reference when comparing omental fat from
obese and non-obese subjects, it is utterly inadequate for the
comparison of omental and subcutaneous fat. As a consequence,
housekeeping proteins to be used as reference standards should be
carefully assayed.
Consequently, we resorted for the first time to 2D-DIGE, MS
and immunoblotting analyses to identify adipose tissue reference
proteins equally expressed in the two major intra-abdominal fat
depots, the omental and the subcutaneous depots, across a wide
adiposity range. In addition, since omental adipose tissue has been
linked to many of the morbidities associated with obesity,
including type 2 diabetes and cardiovascular disease [5,6], we
have searched for reference proteins by comparing omental fat
biopsies from obese and non-obese subjects. In fact, it has been
speculated whether omental fat would be a causal factor, or a
marker of ‘‘dysfunctional adipose tissue’’ [30].
Our study has revealed a trend to increased protein levels in
the omental versus subcutaneous fat (Figure 1 and Figure 2B).
Mesothelium tissue, which is present only in the omental fat [31],
could in some instances account for these increased levels, as is
the case for ENOA, which is also expressed in the mesothelial
cells (Figure 5). Nevertheless, ENOA expression remained steady
in the omental fat from non-obese and obese individuals. It is not
surprising that this highly conserved, multifunctional enzyme
involved in a variety of cellular biological processes such as
growth control, may exert similar functions regardless of obesity
and/or type 2 diabetes states. Likewise, PARK7 showed stable
expression levels in non-obese and obese adipose tissue. The
product of the gene DJ-1 is a highly conserved protein implicated
in a number of cell processes. First identified as an oncogene
driving to abnormal cellular responses related to cell survival
[32], DJ-1 is also recognized as one of the defective genes in
Parkinson disease, due to loss-of-function mutations [33].
Although PARK7 has been found modulated in several
pathological conditions, such as endometriosis and hepatocellular
carcinoma [34,35,36], our results, supported by two techniques,
show that PARK7 is not differentially expressed in obesity. As far
as we know, this protein had not been studied in human adipose
tissue yet. Our findings based on immunohistochemical analyses
have shown for the first time expression of PARK7 in adipocytes,
mesothelial cells and other stromal cells in omental adipose tissue,
supporting its ubiquitous expression [37]. PARK7 antibody
stained mainly the nucleus of cells, but cytoplasm expression was
also observed (Figure 5). It is noteworthy that the optional use of
PARK7 or ENOA (19.9 and 47.2 kDa, respectively) enables
quantitative Western Blot analysis in a wide range of protein
molecular weight.
Conversely, FAA maintained steady expression levels across
paired omental and subcutaneous fat samples. Neither had FAA
been studied in adipose tissue yet; this protein acts as the terminal
enzyme in the tyrosine catabolism pathway, and its defects cause
an autosomal recessive inborn error of metabolism named Type 1
tyrosinemia (HT) which has been studied mostly in liver and
kidney, two of the organs affected in this disorder [38]. To our
knowledge no proteins with comparable expression levels between
omental and subcutaneous adipose tissue have been reported yet.
Immunohistochemical analysis using an FAA antibody provided
further evidence, as mesothelial cells in omental adipose tissue fail
to stain (Figure 5).
Figure 3. Protein expression levels in omental adipose tissue
from non-obese and obese subjects. Representative Western Blot
analysis of Beta-actin, GAPDH, TBB5 and CALX expression in omental fat
samples from non-obese (control) and obese subjects. Relative intensity
values from band densitometry are expressed as mean 6 SD.
doi:10.1371/journal.pone.0030326.g003
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In summary, we have unveiled that neither customary
GAPDH and TBB5 nor CALX can be regarded proper loading
controls in differential protein expression studies on adipose
tissue. Consequently, using proteomic approaches we have
demonstrated that Beta-actin, ENOA and PARK7 are the most
adequate reference standards in obesity studies based on human
omental adipose tissue, whilst FAA is the best loading control for
the comparative analysis of omental and subcutaneous fat depots.
The use of the reference proteins proposed in this work will
facilitate the adequate analysis of proteins differentially expressed
Figure 4. Proteins identified by 2D-DIGE and MS showing sustained expression levels in omental adipose tissue from non-obese
and obese subjects. Protein extracts from omental fat of obese and non-obese subjects were analyzed by 2D-DIGE as described [19]. A selected
silver-stained gel is shown with spots numbered as indicated in Table 1 (A). Sustained expression of PARK7 in obese and non-obese (control) subjects
by DeCyder analysis. Zoomed images of 2D-DIGE gels around PARK7 spot (circled), 3D-view of selected spots (arrow) and graphical representation of
the Standardized Abundance (Log) of PARK7 spot is shown (B). Representative Western Blot analysis of ENOA, PARK7 and FAA expression in omental
fat samples from non-obese and obese subjects. Relative intensity values from band densitometry are expressed as mean 6 SD (C).
doi:10.1371/journal.pone.0030326.g004
Reference Proteins for Expression Studies in Fat
PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e30326
in adipose tissue in the context of obesity, a goal difficult to meet
before this study.
Supporting Information
Figure S1 Protein expression levels in omental adipose
tissue from non-obese and non-diabetic, and type 2
diabetic obese subjects. Representative Western Blot analysis
of ENOA, PARK7, FAA, Beta-actin, GAPDH, TBB5 and CALX
expression in omental fat samples from non-obese and non-
diabetic (control), and type 2 diabetic obese subjects. ENOA,
PARK7 and Beta-actin proteins show steady expression profiles
across samples with CV of 13%, 20% and 28% repectively.
Relative intensity values from band densitometry are expressed as
mean 6 SD.
(TIF)
Table S1 Clinical characteristics of the individuals
included in this study.
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